ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.948,03
1,68%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Evogene Ltd (EVGN)

  7. Evogene Ltd (EVGN) News

EVGN

Evogene (EVGN)

Evogene Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EVGN
DatumZeitQuelleÜberschriftSymbolFirma
16/04/202413h00PR Newswire (US)Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:EVGNEvogene Ltd
11/04/202413h00PR Newswire (US)Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual MeetingNASDAQ:EVGNEvogene Ltd
02/04/202413h00PR Newswire (US)Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food IndustryNASDAQ:EVGNEvogene Ltd
28/03/202414h00PR Newswire (US)Evogene Announces Filing of Annual Report on Form 20-FNASDAQ:EVGNEvogene Ltd
20/03/202414h00PR Newswire (US)Evogene Reports Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:EVGNEvogene Ltd
19/03/202414h00PR Newswire (US)Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse TestingNASDAQ:EVGNEvogene Ltd
13/03/202414h00PR Newswire (US)Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North AmericaNASDAQ:EVGNEvogene Ltd
07/03/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
07/03/202413h00PR Newswire (US)Evogene Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:EVGNEvogene Ltd
06/03/202413h00PR Newswire (US)AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel HerbicidesNASDAQ:EVGNEvogene Ltd
05/03/202413h00PR Newswire (US)Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed VarietiesNASDAQ:EVGNEvogene Ltd
01/03/202413h03Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:EVGNEvogene Ltd
28/02/202413h00PR Newswire (US)Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement RequirementsNASDAQ:EVGNEvogene Ltd
26/02/202413h00PR Newswire (US)Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024NASDAQ:EVGNEvogene Ltd
22/02/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
22/02/202413h00PR Newswire (US)AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive OfficerNASDAQ:EVGNEvogene Ltd
21/02/202413h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
21/02/202413h00PR Newswire (US)AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control SolutionNASDAQ:EVGNEvogene Ltd
20/02/202413h00PR Newswire (US)Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-InsecticideNASDAQ:EVGNEvogene Ltd
15/02/202402h30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EVGNEvogene Ltd
06/02/202413h08PR Newswire (US)Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic InnovationNASDAQ:EVGNEvogene Ltd
23/01/202413h00PR Newswire (US)Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement SummitNASDAQ:EVGNEvogene Ltd
17/01/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
17/01/202413h00PR Newswire (US)Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology DrugNASDAQ:EVGNEvogene Ltd
09/01/202414h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
21/12/202313h00PR Newswire (US)Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024NASDAQ:EVGNEvogene Ltd
19/12/202313h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
19/12/202313h00PR Newswire (US)Casterra Appoints New CEO and Expands Team to Drive Growth and InnovationNASDAQ:EVGNEvogene Ltd
05/12/202313h00PR Newswire (US)Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™NASDAQ:EVGNEvogene Ltd
28/11/202313h00PR Newswire (US)Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and BarleyNASDAQ:EVGNEvogene Ltd
 Showing the most relevant articles for your search:NASDAQ:EVGN

Kürzlich von Ihnen besucht

AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
TG
D7G
Nel ASA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
DBI
DAX
DAX
AMEX
XLE
Energy Select Sector SPDR
CCOM
US100
US Tech 100
FX
EURJPY
Euro vs Yen
TG
LHA
Deutsche Lufthansa
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten